We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Abbott Licenses Prostate Cancer Biomarkers

News   Apr 18, 2012

 
Abbott Licenses Prostate Cancer Biomarkers
 
 
Advertisement
 

RELATED ARTICLES

New Lung Cancer Trial Will Use Personalized Monitoring To Help Predict Relapse

News

A new international Phase 3 clinical trial will use personalized detection tests to look for the earliest signs of relapse in over 300 patients with lung cancer.

READ MORE

Platinum-based Chemo May Improve Survival in Certain Metastatic Pancreatic Cancer Patients

News

Patients with metastatic pancreatic cancer who had germline or somatic mutations in DNA repair genes had better clinical outcomes after platinum-based chemotherapy, compared with patients that did not have these mutations, according to a new study.

READ MORE

Two Biomarkers Help Predict Immunotherapy Response in Metastatic Breast Cancer

News

Two novel biomarkers have been found to correlate with improved outcomes with immunotherapy treatment in metastatic breast cancer and may help to identify the patients most likely to benefit.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE